Clinical Trial Detail

NCT ID NCT02303262
Title A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Sarcoma Alliance for Research through Collaboration
Indications

leiomyosarcoma

Therapies

Gemcitabine + Mocetinostat

Age Groups: adult

No variant requirements are available.